TKI-30

Protein Kinase inhibitor; structure in first source

Also Known As:

6-(2,6-dichlorophenyl)-2-(2-fluorinphenylamino)-8-methyl-8H-pyrido(2,3-d)pyrimidine-7-one

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Neoplasms (Cancer) 10/01/2007 - "Our data collectively indicated that PDGFRbeta-based ELISA assay is a new method available for screening inhibitors targeting PDGFRbeta kinase and TKI-30 is a potential novel anti-cancer agent worthy of being further investigated."

1.	Phosphotransferases (Kinase)